| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |